-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $42 Price Target

Benzinga·09/10/2025 16:45:29
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $42 price target.